Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Acadia Healthcare Company, Inc. (ACHC)

29.51 -0.39 (-1.30%)
At close: October 28 at 4:00:00 PM EDT
29.62 +0.11 (+0.37%)
After hours: October 28 at 4:46:53 PM EDT
Trade ACHC on Coinbase
Chart Range Bar
Loading chart for ACHC
Chart does not reflect overnight price.
  • Previous Close 29.90
  • Open 29.65
  • Bid 21.57 x 200
  • Ask 37.79 x 200
  • Day's Range 29.29 - 30.52
  • 52 Week Range 11.43 - 35.83
  • Volume 2,189,289
  • Avg. Volume 1,710,170
  • Market Cap (intraday) 2.747B
  • Beta (5Y Monthly) 0.62
  • PE Ratio (TTM) --
  • EPS (TTM) -12.42
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 33.79
  • Zacks Rating Neutral

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

www.acadiahealthcare.com

25,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/28/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ACHC
107.96%
S&P 500 (^GSPC)
13.13%

1-Year Return

ACHC
27.36%
S&P 500 (^GSPC)
12.38%

3-Year Return

ACHC
59.03%
S&P 500 (^GSPC)
88.08%

5-Year Return

ACHC
49.45%
S&P 500 (^GSPC)
68.48%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 865.84M
Earnings 10.93M
Profit Margin 1.26%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-1B
-500M
0
500M
-100.0%
-50.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

17.00 Low
33.79 Average
29.51 Current
41.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/23/2026
Analyst Leerink Partners
Rating Action Maintains
Rating Market Perform
Price Action Raises
Price Target 30 -> 33

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -33.44%

  • Return on Assets (ttm)

    3.57%

  • Return on Equity (ttm)

    -41.44%

  • Revenue (ttm)

    3.37B

  • Net Income Avi to Common (ttm)

    -1.13B

  • Diluted EPS (ttm)

    -12.42

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    171.29M

  • Total Debt/Equity (mrq)

    118.06%

  • Levered Free Cash Flow (ttm)

    -104.96M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: